Medical cannabis and/or cannabinoids derived from cannabis have been reported to be an effective treatment strategy for a number of diseases including AIDs wasting syndrome, Alzhiemer’s, arthritis, cancer, gastrointestinal diseases, epilepsy, glaucoma, hepatitis, migraines, multiple sclerosis, along with many other diseases.
Scientific studies have shown cannabis and/or cannabinoids to be able to decrease seizure symptoms in epileptics, halt cancer metastasis, and decrease inflammation. Cannabis and/or cannabinoids have also been widely used in palliative care; relieving pain, nausea, insomnia and other symptoms of disease.
However, different disease states may require unique cannabinoid receptor activation events. Therefore, patients can’t expect a single CBT (cannabinoid based therapeutic) to work for every disease. By understanding the source of the cannabinoid variation and mechanism of action, we can begin to tailor CBTs to better meet the needs of patients.
Click to view condition list
|Amyotrophic Lateral Sclerosis|
|Decrease Blood Pressure|
|Inflammatory Bowel Disease|
|Post-Traumatic Stress Disorder|